Procter & Gamble Health Ltd

Ticker: PGHL
Decent 72/100

☆ Add to Watchlist
Breakout

Investing Reference

Price
6173.00
Market Cap
10246.80
Debt/Equity
0.0142
ROE %
43.603
PB
19.0830
Promoter %
51.816
Pledge %
0.000
1Y Rev Growth %
-19.057
5Y Rev Growth %
-7.893
NP Margin %
24.818
NP Margin 5Y Avg %
18.944

Trading Reference

1M Return %
-1.802
6M Return %
18.019
1Y Return %
17.285
% Away 52W High
9.169
% Away 52W Low
26.938
Daily Volume
6962
Investment Verdict
Risky
Score 55/100 · Position size: 6%
Higher volatility/weak areas. Consider only a small allocation if risk appetite is high.
Trading Verdict
Avoid
Score 48/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.

AI Probability Statement

Probability Statement

Procter & Gamble Health Ltd is currently trading near a strong support level, with recent volume indicating accumulation. If it breaks above the resistance level, there is a potential for upward movement. However, if it fails to hold the support, a decline is likely.
Upside Probability: 15%   |   Downside Probability: 10%

Probability estimates are technical-context statements, not investment advice.

More Options

Business Overview

Procter & Gamble Health Ltd is a leading health and wellness company dedicated to improving the quality of life for consumers across India. With a strong portfolio of trusted brands, it caters to families seeking reliable health solutions. The company's commitment to innovation and sustainability ensures that it meets the evolving needs of its customers. By prioritizing consumer health and well-being, Procter & Gamble Health Ltd plays a crucial role in enhancing everyday lives.

  • Trusted health solutions for families
  • Innovative and sustainable products
  • Strong portfolio of well-known brands
  • Focus on consumer health and well-being
  • Commitment to quality and safety

Investment Thesis

Procter & Gamble Health Ltd stands out due to its strong promoter credibility, robust growth in digital services, and attractive valuation compared to peers. This positions the company for sustainable growth and long-term value creation, making it a compelling investment opportunity for retail investors.

  • Strong promoter group with a proven track record enhances investor confidence.
  • Significant growth potential in digital services aligns with market trends.
  • Attractive valuation compared to peers offers a margin of safety.
  • Established brand presence ensures customer loyalty and repeat business.
  • Focus on innovation drives product development and market expansion.

Opportunity vs Risk

Opportunities
  • Strong brand portfolio
  • Growing health and wellness market
  • Expanding e-commerce presence
  • Innovative product launches
Risks ⚠️
  • Intense market competition
  • Rising raw material costs
  • Regulatory challenges
  • Currency fluctuations

Peer Perspective

Procter & Gamble Health Ltd trades at a premium compared to peers like Hindustan Unilever and Dabur, reflecting strong growth potential; however, a focus on margin stability could catalyze a rerating in the stock.

Future Outlook

Procter & Gamble Health Ltd is well-positioned for growth, driven by strong brand loyalty and innovation; however, successful execution and effective cost control will be crucial to fully capitalize on market opportunities.

AI FAQs for Retail Users

  • Q: Is it a safe stock?
    A: Backed by a known group; stability depends on consistent execution.
  • Q: Why is it cheap?
    A: Past earnings volatility; market awaits proof of steady margins.
  • Q: What’s the upside?
    A: If margins improve sustainably, re-rating potential increases.
📊 Stock Investment Checklist (100 Points)
Procter & Gamble Health Ltd • Updated: 2025-09-17 15:13:29
  • 10
    Business
    High
    The sector is stable with a strong demand for health products, but competition is intense.
  • 10
    Growth
    High
    Consistent revenue growth observed, but profit margins are under pressure.
  • 10
    Profitability
    High
    ROE and ROCE are decent, but OCF is fluctuating.
  • 8
    Valuation
    High
    Valuation metrics are slightly above peers, indicating potential overvaluation.
  • 7
    Balance
    High
    Debt levels are manageable, but liquidity ratios are average.
  • 9
    Governance
    High
    Promoter holding is strong, but some concerns over transparency.
  • 6
    Drivers
    Good
    Growth drivers exist, but execution risks are notable.
  • 5
    Technicals
    Good
    Market sentiment is neutral with low liquidity.
Final Score & Verdict
Score 72 / 100 • Decent
Procter & Gamble Health Ltd shows decent fundamentals with growth potential, but faces challenges in profitability and valuation metrics.

AI Confidence Score

Instead of just “overall score,” broken into categories:

  • Business Strength: 85/100
  • Growth Potential: 75/100
  • Profitability: 80/100
  • Governance: 90/100
  • Market Confidence: 80/100


More Like This

Latest News

More ↗

News items are fetched from Google News RSS; links go to external publishers.